Hepatitis B virus reactivation induced by Yttrium-90-ibritumomab-tiuxetan

被引：5

作者：

Cil, Timucin ^{[1
]}

Altintas, Abdullah

Tuzun, Yekta

Pasa, Semir

Isikdogan, Abdurrahman

机构：

[1] Dicle Univ, Dept Med Oncol, TR-21280 Diyarbakir, Turkey

[2] Dicle Univ, Dept Hematol, TR-21280 Diyarbakir, Turkey

[3] Dicle Univ, Dept Gastroenterol, TR-21280 Diyarbakir, Turkey

来源：

LEUKEMIA & LYMPHOMA | 2007年 / 48卷 / 09期

关键词：

D O I：

10.1080/10428190701509848

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：1866 / 1868

页数：3

共 21 条

[1]

BORG FT, 1998, DIGEST DIS SCI, V43, P2267

[2]

Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma [J].

Clark, FL ;

Drummond, MW ;

Chambers, S ;

Chapman, BA ;

Patton, WN .

ANNALS OF ONCOLOGY, 1998, 9 (04) :385-387

[3]

EFFECTS OF IMMUNOSUPPRESSIVE THERAPY WITH PREDNISOLONE ON LYMPHOCYTE-B AND LYMPHOCYTE-T FUNCTION IN PATIENTS WITH CHRONIC TYPE-B HEPATITIS [J].

HANSON, RG ;

PETERS, MG ;

HOOFNAGLE, JH .

HEPATOLOGY, 1986, 6 (02) :173-179

[4]

LYMPHOMA CLASSIFICATION PROPOSAL - CLARIFICATION [J].

HARRIS, NL ;

JAFFE, ES ;

STEIN, H ;

BANKS, PM ;

CHAN, JKC ;

CLEARY, ML ;

DELSOL, G ;

DEWOLFPEETERS, C ;

FALINI, B ;

GATTER, KC ;

GROGAN, TM ;

ISAACSON, PG ;

KNOWLES, DM ;

MASON, DY ;

MULLERHERMELINK, HK ;

PILERI, SA ;

PIRIS, MA ;

RALFKIAER, E ;

WARNKE, RA .

BLOOD, 1995, 85 (03) :857-860

[5]

Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations [J].

Law, JK ;

Ho, JK ;

Hoskins, PJ ;

Erb, SR ;

Steinbrecher, UP ;

Yoshida, EM .

LEUKEMIA & LYMPHOMA, 2005, 46 (07) :1085-1089

[6]

Leonard John P, 2005, Hematology Am Soc Hematol Educ Program, P335

[7]

LIAG R, 1999, J CLIN ONCOL, V17, P394

[8]

HEPATITIS-B VIRUS-INFECTION IN CHINESE-FAMILIES IN HONG-KONG [J].

LOK, ASF ;

LAI, CL ;

WU, PC ;

WONG, VCW ;

YEOH, EK ;

LIN, HJ .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (03) :492-499

[9]

Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program [J].

McLaughlin, P ;

Grillo-López, AJ ;

Link, BK ;

Levy, R ;

Czuczman, MS ;

Williams, ME ;

Heyman, MR ;

Bence-Bruckler, I ;

White, CA ;

Cabanillas, F ;

Jain, V ;

Ho, AD ;

Lister, J ;

Wey, K ;

Shen, D ;

Dallaire, BK .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2825-2833

[10]

Mehmet D, 2005, JPN J INFECT DIS, V58, P15

← 1 2 3 →